Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Privia Health Group Inc (NASDAQ: PRVA) closed at $19.61 down -5.31% from its previous closing price of $20.71. In other words, the price has decreased by -$5.31 from its previous closing price. On the day, 1.07 million shares were traded. PRVA stock price reached its highest trading level at $21.1 during the session, while it also had its lowest trading level at $19.54.
Ratios:
For a deeper understanding of Privia Health Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.20. For the most recent quarter (mrq), Quick Ratio is recorded 1.88 and its Current Ratio is at 1.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 13 ’25 when Mehrotra Parth sold 15,909 shares for $24.52 per share. The transaction valued at 390,089 led to the insider holds 407,234 shares of the business.
Mehrotra Parth sold 13,773 shares of PRVA for $344,187 on May 12 ’25. The Chief Executive Officer now owns 423,143 shares after completing the transaction at $24.99 per share. On May 12 ’25, another insider, Mountcastle David, who serves as the EVP & Chief Financial Officer of the company, sold 3,322 shares for $24.99 each. As a result, the insider received 83,017 and left with 172,909 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2390851328 and an Enterprise Value of 2390342656. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 158.66, and their Forward P/E ratio for the next fiscal year is 58.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.33 while its Price-to-Book (P/B) ratio in mrq is 3.61. Its current Enterprise Value per Revenue stands at 1.327 whereas that against EBITDA is 83.215.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.82, which has changed by 0.0 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.09, while it has fallen to a 52-week low of $16.47. The 50-Day Moving Average of the stock is -13.48%, while the 200-Day Moving Average is calculated to be -10.67%.
Shares Statistics:
For the past three months, PRVA has traded an average of 838.37K shares per day and 890840 over the past ten days. A total of 121.39M shares are outstanding, with a floating share count of 107.95M. Insiders hold about 11.45% of the company’s shares, while institutions hold 94.43% stake in the company. Shares short for PRVA as of 1749772800 were 3425013 with a Short Ratio of 3.90, compared to 1747267200 on 3559028. Therefore, it implies a Short% of Shares Outstanding of 3425013 and a Short% of Float of 5.09.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 12.0 analysts are actively evaluating the performance of Privia Health Group Inc (PRVA) in the stock market.The consensus estimate for the next quarter is $0.21, with high estimates of $0.25 and low estimates of $0.14.
Analysts are recommending an EPS of between $0.94 and $0.64 for the fiscal current year, implying an average EPS of $0.84. EPS for the following year is $0.96, with 12.0 analysts recommending between $1.1 and $0.73.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $466.97M this quarter.It ranges from a high estimate of $494.32M to a low estimate of $455.4M. As of the current estimate, Privia Health Group Inc’s year-ago sales were $422.33MFor the next quarter, 17 analysts are estimating revenue of $473.56M. There is a high estimate of $505.42M for the next quarter, whereas the lowest estimate is $463.1M.
A total of 17 analysts have provided revenue estimates for PRVA’s current fiscal year. The highest revenue estimate was $2B, while the lowest revenue estimate was $1.88B, resulting in an average revenue estimate of $1.91B. In the same quarter a year ago, actual revenue was $1.74BBased on 17 analysts’ estimates, the company’s revenue will be $2.12B in the next fiscal year. The high estimate is $2.27B and the low estimate is $2.02B.
